Program to help people take oral cancer medicines as prescribed
Part of Cancer clinical trials.
This trial studies whether a team-based clinic visit program can improve how well people stick to their oral (by mouth) cancer medicines. It may help by offering extra support at the start of treatment or after a cancer comes back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak French fluently
- You have been newly diagnosed with cancer or your cancer has come back
- You are starting an oral cancer medicine (taken by mouth)
- You are not in this study if you are only taking hormone therapy
- You should not have a severe psychiatric condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new program of supportive care (extra help for symptoms and well-being) works for people with cancer. It's open to anyone with any type or stage of cancer who has had a needs assessment.
This trial studies whether a “DROP” support program helps ambulatory people with cancer manage drug-related problems when they start or change oral (by mouth) anticancer treatment. It may help reduce medication mistakes and complications by improving how you handle your regimen at home.
This trial tests a program to help teenagers and young adults take their oral cancer medications as prescribed. It aims to make medication routines easier and improve adherence.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
This study is testing a program to help people stick with their daily oral chemo pill. It is for adults who have been taking a single oral cancer treatment for at least six months and want extra support.
Hear when a new Multidisciplinary Consultation Program trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.